{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Design: Prospective phase II trial"
      },
      "Participants": {
        "score": 2,
        "evidence": "Patients with stage cT2N0 rectal adenocarcinomas"
      },
      "Intervention": {
        "score": 2,
        "evidence": "treated with an oxaliplatin/capecitabine-based chemoradiation regimen followed by local excision"
      },
      "Objective": {
        "score": 1,
        "evidence": "Objective: Prospectively assess anorectal function and health-related quality of life"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "assessed at enrollment and 1 year postoperatively"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Seventy-one (98%) patients were evaluated at enrollment and 66 (92%) at 1 year"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Seventy-one (98%) patients were evaluated at enrollment and 66 (92%) at 1 year"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "Fecal Incontinence Quality of Life results were significantly worse in the lifestyle (p<0.001), coping/behavior (p<0.001) and embarrassment (p=0.002) domains"
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 12,
    "max_score": 25
  },
  "model": "gpt-4o"
}